Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
about
Sleep in the Elderly: Burden, Diagnosis, and TreatmentHistory of the development of sleep medicine in the United StatesUpdate on the safety considerations in the management of insomnia with hypnotics: incorporating modified-release formulations into primary careNoise-induced sleep maintenance insomnia: hypnotic and residual effects of zaleplonEvaluation of the efficacy and safety of ramelteon in subjects with chronic insomniaA visual ERP study of impulse inhibition following a zaleplon-induced nap after sleep deprivationThe effects of music relaxation and muscle relaxation techniques on sleep quality and emotional measures among individuals with posttraumatic stress disorder.Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.The societal costs of insomniaMeta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem.Is the increasing use of evidence-based pharmacotherapy causing the renaissance of complementary medicine?The Importance of Residual Effects When Choosing a Hypnotic: The Unique Profile of ZaleplonClinical evaluation of zaleplon in the treatment of insomnia.An approach to long-term sedative-hypnotic useEfficacy and safety of 6-month nightly ramelteon administration in adults with chronic primary insomniaClinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.Dipyrazolo[1,5-a:4',3'-c]pyridines - a new heterocyclic system accessed via multicomponent reaction.The Black Book of Psychotropic Dosing and Monitoring.Predictive Model for Site-Selective Aryl and Heteroaryl C-H Functionalization via Organic Photoredox Catalysis.
P2860
Q24562786-4876F632-102F-4576-AEA3-E98E4962273AQ24644409-E83C554F-F970-4988-AF6F-D9C21BFBB01DQ24670611-4435D09F-8A14-40B9-95CC-CDED395080ACQ24682992-972D0669-726E-491A-A0FA-A9D9C189A9E6Q24683617-B3E58AB6-06F9-4B79-A203-DF3F21409E86Q28538560-C179ACF7-3DAF-4AF4-90E7-1CF2E4198665Q30369428-DA4EE74A-FDD6-4222-90AB-17ED6047A8F5Q34197699-55F3A879-BE9B-40F8-A6AB-EF78F72AA273Q34560329-F7D6CDAC-5F99-409B-B5A0-FC280A60A883Q35016391-82AE7B09-248D-4B91-B4A1-35234E576BEFQ35200060-B6035C84-00E2-41E7-8A88-D772DA697AACQ35665983-9B120724-31E5-42F9-A78C-C76E00B73478Q36779803-C3F73CFD-4E10-49EE-8D5D-F5CC155506DBQ36779890-35F81E01-BEC8-4176-97A5-BEAF0D685307Q37109731-7F35DD9A-700F-4D2C-B992-C3F1E9F3220CQ39044821-66F4F138-E52D-43A0-BFF0-49A62CDFA93AQ41932682-5BB01600-36CB-4523-AD04-DABADC991618Q47642128-36D61126-3917-4529-8643-5360BBF6A7AFQ48109840-19854DF5-C05F-41A0-8C4E-7438EF370B36
P2860
Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
description
1999 nî lūn-bûn
@nan
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Sleep latency is shortened dur ...... Zaleplon Clinical Study Group.
@ast
Sleep latency is shortened dur ...... Zaleplon Clinical Study Group.
@en
type
label
Sleep latency is shortened dur ...... Zaleplon Clinical Study Group.
@ast
Sleep latency is shortened dur ...... Zaleplon Clinical Study Group.
@en
prefLabel
Sleep latency is shortened dur ...... Zaleplon Clinical Study Group.
@ast
Sleep latency is shortened dur ...... Zaleplon Clinical Study Group.
@en
P2093
P1476
Sleep latency is shortened dur ...... Zaleplon Clinical Study Group.
@en
P2093
P304
P577
1999-08-01T00:00:00Z